Shopping Cart
Remove All
Your shopping cart is currently empty
VU534 is a NAPE-PLD agonist with an EC50 of 0.30 μM.VU534 is a dual inhibitor of FAAH and sEH, with an IC50 of 1.2 μM for sEH.VU534 is used in diseases related to cardiometabolism.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $36 | - | In Stock | |
| 5 mg | $84 | - | In Stock | |
| 10 mg | $139 | - | In Stock | |
| 25 mg | $235 | - | In Stock | |
| 50 mg | $353 | - | In Stock | |
| 100 mg | $533 | - | In Stock |
| Description | VU534 is a NAPE-PLD agonist with an EC50 of 0.30 μM.VU534 is a dual inhibitor of FAAH and sEH, with an IC50 of 1.2 μM for sEH.VU534 is used in diseases related to cardiometabolism. |
| Targets&IC50 | FAAH:1.2 μM, sEH:1.2 μM, NAPE-PLD:0.30 μM(EC50) |
| In vitro | VU534 (30 μM; 24 h) is less cytotoxic to HepG2 and Raw264.7 cell lines.[1] VU534 (3~30 μM; 1 h) can increase NAPE-PLD activity in Raw264.7 cells.[1] VU534 (1 h) can increase NAPE-PLD activity in HepG2 cells with an EC50 value of 1.5 μM.[1] VU534 (5 μM, 1 h) increased NAPE-PLD activity 1.5-fold but did not reverse NAPE-PLD activity inhibited by LEI–401.[1] VU534 (10 μM; 6 h) significantly enhances efferocytosis of bone marrow-derived macrophages but cannot exert this effect when Napepld is knocked out.[1] |
| Molecular Weight | 447.55 |
| Formula | C21H22FN3O3S2 |
| Cas No. | 923509-20-0 |
| Smiles | CC1=CC2=C(SC(NC(=O)C3CCN(CC3)S(=O)(=O)C3=CC=C(F)C=C3)=N2)C(C)=C1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO: < 1 mg/mL (insoluble or slightly soluble), Sonication is recommended. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.